Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Multiple Dose Study of JTC-064 in Healthy Volunteers
jRCT2071250054Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in Neurodegenerative disorders (NDDs) comparing JTC-064 with Placebo (2 arms). Primary endpoints: Safety and Pharmacokinetics. Started Aug 2025; status: completed.
02
Drugs
JTC-064
03
Conditions
Neurodegenerative disorders (NDDs)
Beyond the preview
Go deeper on jRCT2071250054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071250054.